Sinphar Pharmaceutical Co Ltd (1734) — Cash Flow-to-Debt Ratio
Sinphar Pharmaceutical Co Ltd (1734) has a Cash Flow-to-Debt Ratio of 0.04x as of March 2026, meaning its operating cash flow of NT$116.42 Million could theoretically repay 0% of its total liabilities (NT$2.61 Billion) in one year. See Sinphar Pharmaceutical Co Ltd (1734) financial flexibility to measure the company's free cash flow as a share of total liabilities.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Sinphar Pharmaceutical Co Ltd Cash Flow-to-Debt Ratio (2003–2025)
Historical debt coverage capacity for Sinphar Pharmaceutical Co Ltd across 23 annual periods. For the full cash flow conversion analysis, see cash efficiency ratio of Sinphar Pharmaceutical Co Ltd.
Annual Cash Flow-to-Debt Ratio for Sinphar Pharmaceutical Co Ltd (2003–2025)
Year-by-year debt coverage analysis for Sinphar Pharmaceutical Co Ltd. Check earnings quality score of Sinphar Pharmaceutical Co Ltd to evaluate the quality of earnings relative to operating cash generation.
| Year | CF-to-Debt Ratio | Operating CF (TWD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.24x | NT$584.66 Million | NT$2.44 Billion | ▲ +11.2% |
| 2024 | 0.22x | NT$593.51 Million | NT$2.75 Billion | ▲ +107.6% |
| 2023 | 0.10x | NT$296.37 Million | NT$2.85 Billion | ▼ -27.5% |
| 2022 | 0.14x | NT$425.30 Million | NT$2.97 Billion | ▲ +232.3% |
| 2021 | 0.04x | NT$135.54 Million | NT$3.14 Billion | ▼ -12.1% |
| 2020 | 0.05x | NT$146.39 Million | NT$2.98 Billion | ▲ +267.5% |
| 2019 | -0.03x | NT$-79.49 Million | NT$2.71 Billion | ▼ -190.5% |
| 2018 | 0.03x | NT$79.50 Million | NT$2.46 Billion | ▼ -64.4% |
| 2017 | 0.09x | NT$219.87 Million | NT$2.42 Billion | ▲ +153.0% |
| 2016 | 0.04x | NT$87.18 Million | NT$2.42 Billion | ▼ -68.9% |
| 2015 | 0.12x | NT$280.53 Million | NT$2.43 Billion | ▲ +85.6% |
| 2014 | 0.06x | NT$148.58 Million | NT$2.39 Billion | ▼ -53.7% |
| 2013 | 0.13x | NT$297.09 Million | NT$2.21 Billion | ▲ +50.9% |
| 2012 | 0.09x | NT$164.45 Million | NT$1.85 Billion | ▼ -21.9% |
| 2011 | 0.11x | NT$225.58 Million | NT$1.98 Billion | ▼ -32.3% |
| 2010 | 0.17x | NT$261.49 Million | NT$1.55 Billion | ▼ -19.0% |
| 2009 | 0.21x | NT$309.94 Million | NT$1.49 Billion | ▲ +39.5% |
| 2008 | 0.15x | NT$271.01 Million | NT$1.82 Billion | ▲ +24.8% |
| 2007 | 0.12x | NT$174.85 Million | NT$1.46 Billion | ▼ -20.4% |
| 2006 | 0.15x | NT$166.57 Million | NT$1.11 Billion | ▲ +46.7% |
| 2005 | 0.10x | NT$122.09 Million | NT$1.19 Billion | ▼ -39.8% |
| 2004 | 0.17x | NT$174.81 Million | NT$1.03 Billion | ▲ +56.9% |
| 2003 | 0.11x | NT$120.84 Million | NT$1.12 Billion | — |